CHU Saint-etienne

Saint-Priest-en-Jarez 42270

0 studies enrolling now · 4 studies all time

What they study most

Crohn Disease, Hidradenitis Suppurativa, Metapneumovirus, Myelodysplastic Syndromes

Studies at this site

• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed
• Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus — Withdrawn before enrolling